These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16252133

  • 1. A comparison of a new oral streptogramin XRP 2868 with quinupristin-dalfopristin against antibiotic-resistant strains of haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae.
    Mabe S, Champney WS.
    Curr Microbiol; 2005 Dec; 51(6):363-6. PubMed ID: 16252133
    [Abstract] [Full Text] [Related]

  • 2. Synergy of streptogramin antibiotics occurs independently of their effects on translation.
    Noeske J, Huang J, Olivier NB, Giacobbe RA, Zambrowski M, Cate JH.
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5269-79. PubMed ID: 24957822
    [Abstract] [Full Text] [Related]

  • 3. Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae.
    Pankuch GA, Hoellman D, Bryskier A, Lowther J, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3914-6. PubMed ID: 17065630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of quinupristin/dalfopristin against gram-positive bacteria Haemophilus influenzae and Branhamella catarrhalis in Taiwan.
    Wang FD, Lin ML, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):433-9. PubMed ID: 10925532
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial characteristics of quinupristin/dalfopristin (Synercid at 30:70 ratio) compared to alternative ratios for in vitro testing.
    Jamjian C, Barrett MS, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Apr; 27(4):129-38. PubMed ID: 9154409
    [Abstract] [Full Text] [Related]

  • 9. Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.
    Pankuch GA, Kelly LM, Lin G, Bryskier A, Couturier C, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3270-4. PubMed ID: 14506040
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes.
    Novotná G, Spízek J, Janata J.
    Folia Microbiol (Praha); 2007 Oct; 52(6):593-9. PubMed ID: 18450221
    [Abstract] [Full Text] [Related]

  • 11. Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae.
    Rodgers W, Frazier AD, Champney WS.
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1632-7. PubMed ID: 23318809
    [Abstract] [Full Text] [Related]

  • 12. Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase.
    Korczynska M, Mukhtar TA, Wright GD, Berghuis AM.
    Proc Natl Acad Sci U S A; 2007 Jun 19; 104(25):10388-93. PubMed ID: 17563376
    [Abstract] [Full Text] [Related]

  • 13. Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae.
    Jorgensen JH, McElmeel ML.
    J Antimicrob Chemother; 1997 May 19; 39 Suppl A():69-73. PubMed ID: 9511067
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE, Lindmark A, Persson I.
    J Chemother; 1989 Jul 19; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract] [Full Text] [Related]

  • 15. In-vitro activity of quinupristin/dalfopristin (Synercid) against isolates of Streptococcus pneumoniae, Staphylococcus aureus and enterococcus spp.
    Johnson AP, Warner M, Speller DC.
    J Antimicrob Chemother; 1997 Oct 19; 40(4):604-5. PubMed ID: 9372437
    [No Abstract] [Full Text] [Related]

  • 16. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V, Bozdogan B, Leclercq R, Garry L, Feger C, Carbon C, Fantin B.
    Antimicrob Agents Chemother; 2001 Apr 19; 45(4):1244-8. PubMed ID: 11257041
    [Abstract] [Full Text] [Related]

  • 17. Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.
    Fantin B, Leclercq R, Merlé Y, Saint-Julien L, Veyrat C, Duval J, Carbon C.
    Antimicrob Agents Chemother; 1995 Feb 19; 39(2):400-5. PubMed ID: 7726505
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.